|
ARL5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.880230E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.209000E-01 |
| Normal-vs-Stage2 |
9.581600E-01 |
| Normal-vs-Stage3 |
4.684300E-02 |
| Normal-vs-Stage4 |
1.431990E-02 |
| Stage1-vs-Stage2 |
7.556000E-01 |
| Stage1-vs-Stage3 |
2.278200E-02 |
| Stage1-vs-Stage4 |
8.104100E-03 |
| Stage2-vs-Stage3 |
9.163700E-02 |
| Stage2-vs-Stage4 |
5.402400E-02 |
| Stage3-vs-Stage4 |
6.183200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.113200E-01 |
| Normal-vs-AfricanAmerican |
3.418500E-03 |
| Normal-vs-Asian |
4.991200E-01 |
| Caucasian-vs-AfricanAmerican |
1.962720E-03 |
| Caucasian-vs-Asian |
7.424200E-01 |
| AfricanAmerican-vs-Asian |
4.216200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.183400E-01 |
| Normal-vs-Female |
4.832000E-01 |
| Male-vs-Female |
2.508400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.155020E-01 |
| Normal-vs-Age(41-60Yrs) |
4.314800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.233970E-01 |
| Normal-vs-Age(81-100Yrs) |
4.841600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.379000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.332600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.106400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.032800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.851200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.785400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.604000E-01 |
| Normal-vs-Grade 2 |
8.938800E-01 |
| Normal-vs-Grade 3 |
5.620400E-02 |
| Normal-vs-Grade 4 |
7.991700E-04 |
| Grade 1-vs-Grade 2 |
8.294800E-01 |
| Grade 1-vs-Grade 3 |
1.348400E-01 |
| Grade 1-vs-Grade 4 |
3.755500E-03 |
| Grade 2-vs-Grade 3 |
3.783400E-03 |
| Grade 2-vs-Grade 4 |
1.65600000001653E-06 |
| Grade 3-vs-Grade 4 |
1.681860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.464200E-01 |
| Normal-vs-ccB subtype |
1.520840E-01 |
| ccA subtype-vs-ccB subtype |
1.772490E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.103600E-01 |
| Normal-vs-N1 |
1.027170E-01 |
| N0-vs-N1 |
2.219000E-01 |
|
|
